UPDATE: RBC Capital Starts MindMed (MNMD) at Outperform, 'Practical Pursuit Of Psychedelic Promise'
Tweet Send to a Friend
(Updated - November 16, 2022 5:08 AM EST)
RBC Capital analyst Brian Abrahams initiates coverage on MindMed (NASDAQ: MNMD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams initiates coverage on MindMed (NASDAQ: MNMD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
